Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Journal of Neurochemistry|November 5, 1997
Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neuronsY Du, R C Dodel, K R Bales, et al.Brain Research. Molecular Brain Research|January 16, 1999
Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell deathR C Dodel, Y Du, K R Bales, et al.Pharmacoeconomics|August 5, 1998
The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysisR C Dodel, M Singer, R Köhne-Volland, et al.Neuroscience|August 6, 1998
Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neuronsR C Dodel, Y Du, K R Bales, et al.Brain Research. Molecular Brain Research|June 19, 1998
The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activationK R Bales, Y Du, R C Dodel, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 1998
Costs of drug treatment in Parkinson's diseaseR C Dodel, K M Eggert, M S Singer, et al.Der Nervenarzt|February 18, 1998
[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs]R C Dodel, M Singer, R Köhne-Volland, et al.Medizinische Klinik (Munich, Germany : 1983)|July 15, 1996
[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy]R C Dodel, S Pepperl, R Köhne-Volland, et al.Journal of Neurochemistry|July 1, 1997
alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma proteinY Du, B Ni, M Glinn, et al.Journal of Neurology|March 15, 2005
Pharmacotherapy of Parkinson's disease in GermanyJ C Möller, Y Körner, R C Dodel, et al.Pageof 4